Article Text

Download PDFPDF

Enter B and W: two new meningococcal vaccine programmes launched
  1. Shamez N Ladhani1,
  2. Mary Ramsay1,
  3. Ray Borrow2,
  4. Andrew Riordan3,
  5. John M Watson4,
  6. Andrew J Pollard5
  1. 1Immunisation Department, Public Health England, London, UK
  2. 2Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UK
  3. 3Department of Infectious Diseases and Immunology, Alder Hey Children's Hospital, Liverpool, UK
  4. 4Department of Health, London, UK
  5. 5Department of Paediatrics, University of Oxford, Children's Hospital, Oxford, UK
  1. Correspondence to Professor Andrew J Pollard, Department of Paediatrics, University of Oxford, Level 2, Children's Hospital, Oxford OX3 9DU, UK; andrew.pollard{at}paediatrics.ox.ac.uk

Abstract

In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis. 1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme. 2

  • Infectious Diseases
  • Immunisation

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Atoms
    R Mark Beattie